INTELLIGENT DEALMAKING®
IN HEALTH CARE MERGERS & ACQUISTIONS
THE BRAFF GROUP DIFFERENCE IS OUR MARKET IMMERSION STRATEGY
Behavioral Health
Behavioral Health
Behavioral health has quickly become the most sought after sector in health care M&A, with broad-based interest in residential and community based addictions and substance abuse, mental health, intellectual and developmental disabilities, and autism services providers.
Digital Health
Digital Health
Digital Health will be the bridge from fee-for-service to value-based care. With the stakes so high, the demand for – and valuation of – companies with technology-enabled tools to provide the right care, to the right patient, in the right setting, at the right time is extraordinary – and growing.
Home Health, Home Care, and Hospice
Home Health, Home Care, and Hospice
For the first time, every segment in home health and hospice – Medicare, Medicaid, and private duty – are pinging at the same time as buyers seek to build diversified post-acute continuums that address emerging alternative payment models.
Pharmacy
Pharmacy
While Specialty Rx captures the M&A headlines, the demand for traditional Home Infusion Therapy – and its substantially higher margins – far outstrips supply.
Urgent Care
Urgent Care
Although the M&A market for urgent care has softened a little since 2014 and 2015, the breadth of buyers interested in the space – notably hospitals, physician groups, and insurers that see urgent care as a critical gatekeeping mechanism – remains impressive.
Health Care Staffing
Health Care Staffing
As a result of the ACA, more covered beneficiaries have accessed the health care system, stimulating both demand for, and M&A interest in, health care staffing. The looming question? Whether reform initiatives will drive down hospital occupancy rates and blunt the conditions that gave rise to this renaissance of activity.
Home Medical Equipment
Home Medical Equipment
Now that competitive bid-like pricing has been rolled out nationally, the home medical equipment sector may well be entering a period of sustained stability – a period that may provide buyers with just enough go-forward confidence to begin selectively investing in the space again.
Ancillary Services
Ancillary Services
Given our extensive knowledge of the market forces driving health care M&A, we have been entrusted by providers adjacent to our core to lead their divestiture efforts.
Recent News
SUD Deal Outlook is as ‘Bright as it Has Ever Been’
While deal activity varied by quarter last year, the space saw 51 deals overall in 2020. That’s just two fewer than the 53 transactions it posted in 2019, according to The Braff Group. And currently, the outlook for SUD M&A is “about as bright as it has ever been,” according to Dexter Braff, president of the M&A advisory firm.
Focus on Quality in Value-Based Care Could Impact Hospice M&A
“To stay successful and really be effective at managing your revenue cycle management, it’s getting more sophisticated than it used to be for hospice providers. There’s going to be various iterations of programs coming up and policies that are going to require different payers, and you’ve got to be able to partner with those different payers,” Kulik told Hospice News. “That is something that’s going to be new for hospice providers — that sophistication level.”
Private Investors Pour $25 Million Into DME Startup Tomorrow Health
"Tomorrow Health’s infusion of cash is indicative of rising investor interest in the home-based care space and associated industries like DME. Private equity hospice transactions rose nearly 25% from 2011 to 2020, according to a report from The Braff Group."
What 2020’s Platform Deal Drop Off Means for the Autism Services Market
“A lot of people in the merger and acquisition world, across the board, believe that 2021 might be a record year in terms of transactions,” Braff said. “It could, in fact, be a record year in autism services as well.”